Almost two years after finally pulling the plug on a big non-opioid painkiller programme, Eli Lilly has ... royalty rate. Lilly’s last attempt to develop a non-opioid pain drug was with Pfizer ...
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer ...
One of the highlights of Eli Lilly's third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been ...
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results